Neonatal Cystic Fibrosis Screening in Latvia: A Pilot Project
By: Baiba Lāce, Santa Grīnblate, Liene Korņejeva, Vija Švābe, Ineta Grauduma, Pārsla Vēvere, Rita Lugovska, Alvils Krams and Agris Martinsons
Open Access
|Nov 2009References
- Anonymous (2009).
- Bobadilla, J., L., Farrell, M.H., Farrell, P.M. (2002). Applyingmolecular genetics to facilitate the diagnosis of cystic fibrosis through screening.,, 131-190.
- Corbetta, C., Seia, M., Bassotti, A., Ambrosioni, A., Giunta, A., Padoan, R. (2002). Screening for cystic fibrosis in newborn infants: Results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population., 60-63.
- Ferec, C., Casals, T., Chuzhanova, N., Macek, M., Bienvenu, T. (2006). Gross genomic rearrangements involving deletions in thegene: Characterization of six new events from a large cohort of hitherto unidentified cystic fibrosis chromosomes and meta-analysis of the underlying mechanisms.,, 567-576.
- Hammond, K.B., Abman, S.H., Sokol, R.J., Accurso, F.J. (1991). Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations., 769-774.
- Kerem, B.S., Buchanan, J.A., Durie, P., Corey, M.L., Levison, H., Rommens, J.M., Buchwald, M., Tsui, L.C. (1989). DNA marker haplotype association with pancreatic insufficiency in cystic fibrosis.,, 827-834.
- Kloosterboer, M., Hoffman, G., Rock, M., Gershan, W., Laxova, A., Li, Z., Farrell, P. (2009). Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen., 338-346.
- Krumina, A., Kroshkina, V., Krumina, L., Svabe, V., Krumina, Z., Tamane, I., Baumanis, V. (2001). Cystic fibrosis mutation dF508 in the Latvian population., 161-166.
- Loeber, J.G. (2007). Neonatal screening in Europe; the situation in 2004.,, 430-438.
- Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D. (2001). Cystic fibrosis. In:New York: McGraw-Hill Medical Publishing Division, 8edition, Vol. 3, 5121-5173.
- Sims, E.J., Clark, A., McCormick, J., Mehta, G., Connett, G., Mehta, A. (2007). United Kingdom Cystic Fibrosis Database Steering Committee. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.,(1), 19-28.
- Svabe, V., Krumina, A. (2001). Latvijas Cistiskās fibrozes slimnieku klīniskā stāvokła novērtējums [Evaluation of CF patients' clinical symptoms in Latvia]., 128-130.
- Wilcken, B., Wiley, V. (2003). Newborn screening methods for cystic fibrosis., 272-277.
- Znotina, I., Svabe, V., Teibe U. (2006). Cistiskās fibrozes slimnieku dzīvildzes izmaiņas Latvijā atkarībā no terapijas [Therapy influence to life expectancy of CF patients in Latvia]., 345-349.
DOI: https://doi.org/10.2478/v10046-009-0032-7 | Journal eISSN: 2255-890X (formerly 1407-009X) | Journal ISSN: 1407-009X
Language: English
Page range: 147 - 150
Published on: Nov 6, 2009
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2009 Baiba Lāce, Santa Grīnblate, Liene Korņejeva, Vija Švābe, Ineta Grauduma, Pārsla Vēvere, Rita Lugovska, Alvils Krams, Agris Martinsons, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons License.